Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
Ben SeltzerGeriatric Research, Education and Clinical Center, VA Boston Healthcare System, Department of Neurology, Harvard Medical School, Boston, MA, USAAbstract: An extended release form of the cholinesterase inhibitor (ChEI) drug galantamine (galantamine-ER) was developed, chiefly to increase ad...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Dove Medical Press
2009-12-01
|
| Цуврал: | Clinical Interventions in Aging |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.dovepress.com/galantamine-er-for-the-treatment-of-mild-to-moderate-alzheimerrsquos-d-peer-reviewed-article-CIA |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|